Fig. 5

Overview of the participants’ demographics and experimental protocol characteristics. A Percentage distribution of the pathologies of the participants included in the reviewed studies. B Percentage distribution of main control conditions in the studies. C Histograms of number of participants (top left), number of sessions (top right), "session frequency" (times per week; bottom left), and session duration (bottom right) across the selected studies